Minimally Invasive Esophagectomy Pain Control Trial
Launched by SWEDISH MEDICAL CENTER · Jun 7, 2023
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
The Minimally Invasive Esophagectomy Pain Control Trial is a research study aimed at finding better ways to manage pain after patients have surgery to remove part of the esophagus, which is the tube that connects the throat to the stomach. In this trial, researchers are comparing three different methods of pain relief: a technique that blocks nerves in the chest area, another method that combines nerve blocking with a special freezing technique, and a third method that uses a continuous pain relief catheter along with nerve blocks. The goal is to see which method works best to help patients feel more comfortable during their recovery.
To be part of this study, participants must be adults aged 65 to 74 who are scheduled for a specific type of minimally invasive esophagus surgery at Swedish Medical Center-First Hill. People who cannot agree to participate, are under 18, have had previous chest surgeries, or have certain medical conditions may not be eligible. Those who join the study can expect to receive one of the three pain management techniques during their surgery and will help researchers learn which method might help future patients have a smoother recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- All adult individuals who undergo an esophagectomy with an intended minimally invasive approach of the chest at Swedish Medical Center-First Hill. These approaches include:
- • 3-hole with R video-assisted thoracoscopic surgery (VATS)
- • Ivor Lewis R VATS
- Exclusion Criteria:
- • Age \<18
- • Unable to consent
- • Additional surgical procedures planned
- • Patients with previous thoracic surgery
- • Patient with chronic pain on a daily regimen of narcotics
- • Non-English speaking
- • Contraindications to neuraxial anesthesia (ongoing anticoagulation, anticipated post-operative therapeutic anticoagulation, spinal cord stimulators, anatomic abnormalities preventing epidural placement)
About Swedish Medical Center
Swedish Medical Center is a leading healthcare institution renowned for its commitment to advancing medical research and improving patient care through clinical trials. With a focus on innovation and evidence-based practices, Swedish Medical Center collaborates with a diverse range of stakeholders, including academic institutions and pharmaceutical companies, to conduct rigorous clinical research across various therapeutic areas. The center prioritizes patient safety and ethical standards, ensuring that all trials are designed to enhance treatment outcomes while contributing to the broader medical community's knowledge. By fostering a collaborative environment, Swedish Medical Center aims to translate research findings into actionable clinical practices, ultimately benefiting the patients it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Brian Louie, M.D.
Principal Investigator
Swedish Cancer Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported